Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MitoQ in NAFLD
NCT01167088Phase 2Terminated
- Sponsor
- Antipodean Pharmaceuticals, Inc.
- Start
- Nov 2010
- Primary completion
- Jun 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of mitoquinone in non-alcoholic fatty liver disease (NAFLD), sponsored by Antipodean Pharmaceuticals, Inc.. Started Nov 2010; status: terminated.
02
Drugs
mitoquinone
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT01167088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01167088.